Seikagaku Launches HyLink Viscosupplement for Knee Osteoarthritis

Seikagaku commenced Taiwan launch of HyLink®, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis, through TCM Biotech International.

The main ingredient of HyLink is a cross-linked hyaluronate hydrogel made using Seikagaku’s crosslinking technology. Since the highly viscoelastic hyaluronate hydrogel...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0